STA
PFE icon

Smith Thornton Advisors’s Pfizer PFE Stock Holding History

Smith Thornton Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
8,418
+528
+7% +$13.8K 0.09% 136
2026
Q1 		$222K Buy
+7,890
New +$210K 0.11% 121
2025
Q4 		– Sell
-8,170
Closed -$208K – 131
2025
Q3 		$208K Buy
+8,170
New +$202K 0.11% 127
2025
Q1 		– Sell
-7,848
Closed -$208K – 138
2024
Q4 		$208K Sell
7,848
-3,187
-29% -$86.4K 0.13% 136
2024
Q3 		$319K Sell
11,035
-85
-0.8% -$2.48K 0.21% 106
2024
Q2 		$311K Buy
+11,120
New +$306K 0.23% 103

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Smith Thornton Advisors's PFE Position: Q2 2026 in Review

Smith Thornton Advisors increased its Pfizer (PFE) stake by 6.7% in Q2 2026, buying an estimated $13.8K and bringing the position to 8,418 shares worth $206K. The position accounts for 0.09% of the portfolio, ranked #136.

Smith Thornton Advisors first reported a position in PFE in Q2 2024 and has held it in 6 quarters since. The position peaked at $319K in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Smith Thornton Advisors held 8,418 shares of Pfizer worth $206K as of Q2 2026.
  • Smith Thornton Advisors bought 528 Pfizer shares in Q2 2026, an estimated $13.8K.
  • Pfizer made up 0.09% of Smith Thornton Advisors's portfolio in Q2 2026, its #136 holding.
  • Smith Thornton Advisors first reported a position in Pfizer in Q2 2024 and has held it in 6 quarters since.
  • Smith Thornton Advisors's Pfizer position peaked at $319K in Q3 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Smith Thornton Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.